Sébastien Lazzarotto, Gérard Michel, Carine Domenech, Marie-Dominique Tabone, Sophie Ansoborolo, Jean-Hugues Dalle, André Baruchel, Aurélie Phulpin, Catherine Paillard, Virginie Gandemer, Laura Olivier, Corinne Armari-Alla, Maryline Poiree, Nicolas Sirvent, Justyna Kanold, Sandrine Thouvenin, Isabelle Pellier, Yves Reguerre, Pascale Schneider, Alaa Mustafa Shawket, David Romano, Zeinab Hamidou, Julie Berbis, Martin Postzich, Pascal Auquier, Karine Baumstarck

J Epidemiol Popul Health. 2025 Dec;73(6):203155. doi:10.1016/j.jeph.2025.203155. Epub 2025 Nov 18. PMID: 41259929.

https://pubmed.ncbi.nlm.nih.gov/41259929/

Abstract

Background: Hearing dysfunction following ototoxic or intensive cancer treatments is an underreported late effect among survivors of childhood and adolescent acute leukemia. The AUD&LEA project is the first study to examine, in a large cohort of childhood acute leukemia survivors: 1. the associated factors of hearing loss; 2. the association of hearing loss and the life of the individuals.

Methods: The AUD&LEA (AUDition & Leucémie Enfants et Adolescents) project was a cross-sectional study. The participants were included in the French LEA cohort which includes 18 French medical teams. The inclusion criteria of the patients were: childhood acute leukemia survivors, diagnosed before the age of 18 and after 1980, had a valid response (yes or no) regarding auditory sequela, and alive on December 31, 2022. The following data were collected: sociodemographics and clinical data, quality of life and schooling course.

Results: Among 6145 individuals, 1.45 % (95 % confidence interval [1.11-1.69 %]) persons were classified having a hearing loss. Compared to the individuals without hearing loss, those with hearing loss were significantly younger at the diagnosis and presented more often an acute myeloid disease. They also reported the worst level of quality of life and more often grade retention.

Conclusion: Hearing loss should have consequences in the quality of life and the schooling course. It is essential to carry out systematic screening during and after the implicated treatments.

Keywords: Childhood and adolescent leukemia; Ototoxicity; Quality of life; Survivors.

Abstract

Consult other publications

46.Chronic graft-versus-host disease in long-term survivors of childhood leukemia

45. Genomics of Long-Term Complications of Childhood Leukemia : Rationale and Design of the GenLEA Study

43. Long-term kidney complications in childhood leukemia survivors: a study from the Childhood and Adolescent Leukemia (LEA) project

42. How I treat long-term survivors of childhood acute leukemia

41. Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population

40. Impact of childhood leukemia on siblings: their long-term perception of family functioning and its relationship with their psychosocial characteristics using structural equation modeling

39. Misconceptions and beliefs around hormone replacement therapy after childhood hematopoietic stem cell transplantation: A qualitative study among women leukemia survivors

38. Ovarian Function and Spontaneous Pregnancy After Hematopoietic Stem Cell Transplantation for Leukemia Before Puberty: An L.E.A. Cohort Study

37. Symptomatic osteonecrosis in French survivors of childhood and adolescent leukemia: a clinical and MRI study of LEA cohort

36. The uterine volume is dramatically decreased after hematopoietic stem cell transplantation during childhood regardless of the conditioning regimen

35. Brothers and sisters of childhood acute leukemia survivors: Their long-term quality of life and its determinants

34. Bone mineral density evolution and its determinants in long-term survivors of childhood acute leukemia: a L.E.A. study

33. Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study

32. Quality of life in parents of childhood leukemia survivors. A French Childhood Cancer Survivor Study for Leukemia study.

31. Lipodystrophy-like features after total body irradiation among survivors of childhood acute leukemia.

30. Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population.

29. Adolescence and Socioeconomic Factors: Key Factors in the Long-Term Impact of Leukemia on Scholastic Performance—A LEA Study.

28. Metabolic Syndrome Among Leukemia Survivors: Still Delineating the Risk.

27. A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers – DeNaCaPST programme.

26. Late effects in survivors of infantile acute leukemia: a study of the L.E.A program.

25. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study.

24. Employment in French young adult survivors of childhoodleukemia: an LEA study (for Leucemies de l’Enfant et de l’Adolescent—childhood and adolescent leukemia)

23. The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l’Enfant et de L’Adolescent Study.

22. Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.

21. Educational and occupational outcomes of childhood cancer survivors 30 years afterdiagnosis: a French cohort study.

20. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.

19. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study.

18. Quality of life in minor siblings of childhood leukemia survivors, long-term after diagnosis: A LEA study (for Leucemies de l’Enfant et de l’Adolescent – childhood and adolescent leukemia).

17. Late cardiomyopathy in childhood acute myeloid leukemia survivors: an L.E.A. study.

16. Childhood cancer survivor cohorts in Europe.

15. Health status and quality of life of long-term survivors of childhood acute leukemia: the impact of central nervous system irradiation.

14. Cohort Profile: The French Childhood Cancer Survivor Study For Leukaemia (LEA Cohort).

13. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study.

12. Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.

11. Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.

10. Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood.

9. A French Cohort of Childhood Leukemia Survivors: Impact of Hematopoietic Stem Cell Transplantation on Health Status and Quality of Life.

8. Adherence to Leukemia Maintenance Therapy: A Comparative Study Among Children, Adolescents, and Adults.

7. The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): Development and validation of an instrument to measure the quality of life of the caregivers of patients with cancer.

6. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-UpStudy (LEA).

5. Bone mineral density in adult-survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities.

4. Quality of life in a heterogeneous sample of caregivers of cancer patients: an in-depth interview study.

3. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia.

2. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI.

1. Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation.